Literature DB >> 25972096

Transporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions.

Robert Gharavi1, William Hedrich, Hongbing Wang, Hazem E Hassan.   

Abstract

Opioid-related deaths, abuse, and drug interactions are growing epidemic problems that have medical, social, and economic implications. Drug transporters play a major role in the disposition of many drugs, including opioids; hence they can modulate their pharmacokinetics, pharmacodynamics and their associated drug-drug interactions (DDIs). Our understanding of the interaction of transporters with many therapeutic agents is improving; however, investigating such interactions with opioids is progressing relatively slowly despite the alarming number of opioids-mediated DDIs that may be related to transporters. This review presents a comprehensive report of the current literature relating to opioids and their drug transporter interactions. Additionally, it highlights the emergence of transporters that are yet to be fully identified but may play prominent roles in the disposition of opioids, the growing interest in transporter genomics for opioids, and the potential implications of opioid-drug transporter interactions for cancer treatments. A better understanding of drug transporters interactions with opioids will provide greater insight into potential clinical DDIs and could help improve opioids safety and efficacy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25972096     DOI: 10.1007/s11095-015-1711-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  233 in total

Review 1.  Solute carrier transporters as targets for drug delivery and pharmacological intervention for chemotherapy.

Authors:  Takeo Nakanishi; Ikumi Tamai
Journal:  J Pharm Sci       Date:  2011-05-31       Impact factor: 3.534

2.  Pharmacokinetics of tramadol is affected by MDR1 polymorphism C3435T.

Authors:  Ondrej Slanar; Milan Nobilis; Jaroslav Kvétina; Olga Matousková; Jeffrey R Idle; Frantisek Perlík
Journal:  Eur J Clin Pharmacol       Date:  2007-01-30       Impact factor: 2.953

3.  Methadone inhibits rhodamine123 transport in Caco-2 cells.

Authors:  E Störmer; M D Perloff; L L von Moltke; D J Greenblatt
Journal:  Drug Metab Dispos       Date:  2001-07       Impact factor: 3.922

4.  Coadministration of oral cyclosporin A enables oral therapy with paclitaxel.

Authors:  J M Meerum Terwogt; M M Malingré; J H Beijnen; W W ten Bokkel Huinink; H Rosing; F J Koopman; O van Tellingen; M Swart; J H Schellens
Journal:  Clin Cancer Res       Date:  1999-11       Impact factor: 12.531

5.  Pharmacokinetic-pharmacodynamic modelling of morphine transport across the blood-brain barrier as a cause of the antinociceptive effect delay in rats--a microdialysis study.

Authors:  M R Bouw; M Gårdmark; M Hammarlund-Udenaes
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

6.  Methadone maintenance treatment and St. John's Wort - a case report.

Authors:  D Eich-Höchli; R Oppliger; K Powell Golay; P Baumann; C B Eap
Journal:  Pharmacopsychiatry       Date:  2003-01       Impact factor: 5.788

7.  Coexistence of passive and proton antiporter-mediated processes in nicotine transport at the mouse blood-brain barrier.

Authors:  Salvatore Cisternino; Hélène Chapy; Pascal André; Maria Smirnova; Marcel Debray; Jean-Michel Scherrmann
Journal:  AAPS J       Date:  2012-12-05       Impact factor: 4.009

8.  Transport characteristics of tramadol in the blood-brain barrier.

Authors:  Atsushi Kitamura; Kei Higuchi; Takashi Okura; Yoshiharu Deguchi
Journal:  J Pharm Sci       Date:  2014-08-29       Impact factor: 3.534

9.  Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene.

Authors:  Deanna L Kroetz; Christiane Pauli-Magnus; Laura M Hodges; Conrad C Huang; Michiko Kawamoto; Susan J Johns; Doug Stryke; Thomas E Ferrin; Joseph DeYoung; Travis Taylor; Elaine J Carlson; Ira Herskowitz; Kathleen M Giacomini; Andrew G Clark
Journal:  Pharmacogenetics       Date:  2003-08

10.  Effect of probenecid on the distribution and elimination of ciprofloxacin in humans.

Authors:  U Jaehde; F Sörgel; A Reiter; G Sigl; K G Naber; W Schunack
Journal:  Clin Pharmacol Ther       Date:  1995-11       Impact factor: 6.875

View more
  5 in total

1.  Morphine Accumulates in the Retina Following Chronic Systemic Administration.

Authors:  Nikolas Bergum; Casey-Tyler Berezin; Gregory Dooley; Jozsef Vigh
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-25

Review 2.  Opioids and the Blood-Brain Barrier: A Dynamic Interaction with Consequences on Drug Disposition in Brain.

Authors:  Catarina Chaves; Fernando Remiao; Salvatore Cisternino; Xavier Decleves
Journal:  Curr Neuropharmacol       Date:  2017-11-14       Impact factor: 7.363

3.  An Investigation into Proteomic Constituents of Cerebrospinal Fluid in Patients with Chronic Peripheral Neuropathic Pain Medicated with Opioids- a Pilot Study.

Authors:  Jonathan Royds; Hilary Cassidy; Melissa J Conroy; Margaret R Dunne; David Matallanas; Joanne Lysaght; Connail McCrory
Journal:  J Neuroimmune Pharmacol       Date:  2020-11-20       Impact factor: 4.147

Review 4.  Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk management.

Authors:  Xiu-Qin Feng; Ling-Ling Zhu; Quan Zhou
Journal:  J Pain Res       Date:  2017-05-24       Impact factor: 3.133

5.  Pharmacokinetic Drug Interaction Study of Sorafenib and Morphine in Rats.

Authors:  Agnieszka Karbownik; Danuta Szkutnik-Fiedler; Tomasz Grabowski; Anna Wolc; Joanna Stanisławiak-Rudowicz; Radosław Jaźwiec; Edmund Grześkowiak; Edyta Szałek
Journal:  Pharmaceutics       Date:  2021-12-16       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.